T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy

Por Houot, Roch, Levy, Ronald
Publicado em 2009

CD137 stimulation enhances the vaccinal effect of anti-tumor antibodies

Por Houot, Roch, Kohrt, Holbrook
Publicado no Oncoimmunology (2014)

Boosting antibody-dependant cellular cytotoxicity against tumor cells with a CD137 stimulatory antibody

Por Houot, Roch, Kohrt, Holbrook, Levy, Ron
Publicado em 2012

Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137 Expressing Regulatory T Cells

Por Goldstein, Matthew J, Kohrt, Holbrook E, Houot, Roch, Varghese, Bindu, Lin, Jack T, Swanson, Erica, Levy, Ronald
Publicado em 2012

Combination strategies to enhance antitumor ADCC

Por Kohrt, Holbrook E, Houot, Roch, Marabelle, Aurélien, Cho, Hearn Jay, Osman, Keren, Goldstein, Matthew, Levy, Ronald, Brody, Joshua
Publicado em 2012

B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression

Por Irish, Jonathan M., Myklebust, June H., Alizadeh, Ash A., Houot, Roch, Sharman, Jeff P., Czerwinski, Debra K., Nolan, Garry P., Levy, Ronald
Publicado em 2010

Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by T(reg) depletion

Por Houot, Roch, Goldstein, Matthew J., Kohrt, Holbrook E., Myklebust, June H., Alizadeh, Ash A., Lin, Jack T., Irish, Jonathan M., Torchia, James A., Kolstad, Arne, Chen, Lieping, Levy, Ronald
Publicado em 2009

Sequential tumor and dual immune targeted immunotherapy: anti-lymphoma activity of Rituximab with 4-1bb stimulation and PD-1 blockade

Por Mueller, Antonia MS, Hebb, Jonathan, Sagiv-Barfi, Idit, Marabelle, Aurelien, Houot, Roch, Rajapaksa, Amanda, Czerwinski, Debra K, Chang, Serena, Chester, Cariad, Sadaram, Mohith, Waller, Erin, Levy, Ronald, Kohrt, Holbrook
Publicado no J Immunother Cancer (2014)

High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells

Por Myklebust, June H., Irish, Jonathan M., Brody, Joshua, Czerwinski, Debra K., Houot, Roch, Kohrt, Holbrook E., Timmerman, John, Said, Jonathan, Green, Michael R., Delabie, Jan, Kolstad, Arne, Alizadeh, Ash A., Levy, Ronald
Publicado em 2013

CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies

Por Kohrt, Holbrook E., Houot, Roch, Goldstein, Matthew J., Weiskopf, Kipp, Alizadeh, Ash A., Brody, Josh, Müller, Antonia, Pachynski, Russell, Czerwinski, Debra, Coutre, Steven, Chao, Mark P., Chen, Lieping, Tedder, Thomas F., Levy, Ronald
Publicado em 2011

Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer

Por Kohrt, Holbrook E., Houot, Roch, Weiskopf, Kipp, Goldstein, Matthew J., Scheeren, Ferenc, Czerwinski, Debra, Colevas, A. Dimitrios, Weng, Wen-Kai, Clarke, Michael F., Carlson, Robert W., Stockdale, Frank E., Mollick, Joseph A., Chen, Lieping, Levy, Ronald
Publicado em 2012

Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling

Por Myklebust, June H., Brody, Joshua, Kohrt, Holbrook E., Kolstad, Arne, Czerwinski, Debra K., Wälchli, Sébastien, Green, Michael R., Trøen, Gunhild, Liestøl, Knut, Beiske, Klaus, Houot, Roch, Delabie, Jan, Alizadeh, Ash A., Irish, Jonathan M., Levy, Ronald
Publicado no Blood (2017)

Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma

Por Bachy, Emmanuel, Houot, Roch, Morschhauser, Franck, Sonet, Anne, Brice, Pauline, Belhadj, Karim, Cartron, Guillaume, Audhuy, Bruno, Fermé, Christophe, Feugier, Pierre, Sebban, Catherine, Delwail, Vincent, Maisonneuve, Hervé, Le Gouill, Steven, Lefort, Sophie, Brousse, Nicole, Foussard, Charles, Salles, Gilles
Publicado em 2013

CD137 Is Expressed in Follicular Dendritic Cell Tumors and in Classical Hodgkin and T-Cell Lymphomas: Diagnostic and Therapeutic Implications

Por Anderson, Matthew W., Zhao, Shuchun, Freud, Aharon G., Czerwinski, Debra K., Kohrt, Holbrook, Alizadeh, Ash A., Houot, Roch, Azambuja, Denize, Biasoli, Irene, Morais, José Carlos, Spector, Nelson, Molina-Kirsch, Hernan F., Warnke, Roger A., Levy, Ronald, Natkunam, Yasodha
Publicado em 2012

Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment

Por Alizadeh, Ash A., Gentles, Andrew J., Alencar, Alvaro J., Liu, Chih Long, Kohrt, Holbrook E., Houot, Roch, Goldstein, Matthew J., Zhao, Shuchun, Natkunam, Yasodha, Advani, Ranjana H., Gascoyne, Randy D., Briones, Javier, Tibshirani, Robert J., Myklebust, June H., Plevritis, Sylvia K., Lossos, Izidore S., Levy, Ronald
Publicado em 2011

Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop

Por Houot, Roch, Gaulard, Philippe, Schreiber, Robert, Mellman, Ira, Lambotte, Olivier, Coulie, Pierre G., Fest, Thierry, Korman, Alan, Levy, Ronald, Shipp, Margaret, Tarte, Karin, Kohrt, Holbrook, Marabelle, Aurélien, Ansell, Stephen, Watier, Hervé, van Elsas, Andrea, Balakumaran, Arun, Arce Vargas, Frederick, Quezada, Sergio A., Salles, Gilles, Olive, Daniel
Publicado no Oncoimmunology (2016)

Targeting CD137 enhances the efficacy of cetuximab

Por Kohrt, Holbrook E., Colevas, A. Dimitrios, Houot, Roch, Weiskopf, Kipp, Goldstein, Matthew J., Lund, Peder, Mueller, Antonia, Sagiv-Barfi, Idit, Marabelle, Aurelien, Lira, Ruth, Troutner, Emily, Richards, Lori, Rajapaska, Amanda, Hebb, Jonathan, Chester, Cariad, Waller, Erin, Ostashko, Anton, Weng, Wen-Kai, Chen, Lieping, Czerwinski, Debra, Fu, Yang-Xin, Sunwoo, John, Levy, Ronald
Publicado em 2014

Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network

Por Langner-Lemercier, Sophie, Houillier, Caroline, Soussain, Carole, Ghesquières, Hervé, Chinot, Olivier, Taillandier, Luc, Soubeyran, Pierre, Lamy, Thierry, Morschhauser, Franck, Benouaich-Amiel, Alexandra, Ahle, Guido, Moles-Moreau, Marie-Pierre, Moluçon-Chabrot, Cécile, Bourquard, Pascal, Damaj, Ghandi, Jardin, Fabrice, Larrieu, Delphine, Gyan, Emmanuel, Gressin, Remy, Jaccard, Arnaud, Choquet, Sylvain, Brion, Annie, Casasnovas, Olivier, Colin, Philippe, Reman, Oumedaly, Tempescul, Adrian, Marolleau, Jean-Pierre, Fabbro, Michel, Naudet, Florian, Hoang-Xuan, Khê, Houot, Roch
Publicado no Neuro Oncol (2016)

Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma

Por Merryman, Reid W., Kim, Haesook T., Zinzani, Pier Luigi, Carlo-Stella, Carmelo, Ansell, Stephen M., Perales, Miguel-Angel, Avigdor, Abraham, Halwani, Ahmad S., Houot, Roch, Marchand, Tony, Dhedin, Nathalie, Lescaut, Willy, Thiebaut-Bertrand, Anne, François, Sylvie, Stamatoullas-Bastard, Aspasia, Rohrlich, Pierre-Simon, Labussière Wallet, Hélène, Castagna, Luca, Santoro, Armando, Bachanova, Veronika, Bresler, Scott C., Srivastava, Amitabh, Kim, Harim, Pesek, Emily, Chammas, Marie, Reynolds, Carol, Ho, Vincent T., Antin, Joseph H., Ritz, Jerome, Soiffer, Robert J., Armand, Philippe
Publicado no Blood (2017)

Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study

Por Reboursiere, Emilie, Bras, Fabien Le, Herbaux, Charles, Gyan, Emmanuel, Clavert, Aline, Morschhauser, Franck, Malak, Sandra, Sibon, David, Broussais, Florence, Braun, Thorsten, Fornecker, Luc-Matthieu, Garidi, Reda, Tricot, Sabine, Houot, Roch, Joly, Bertrand, Abarah, Wajed, Choufi, Bachra, Pham, Anne-Dominique, Gac, Anne-Claire, Fruchart, Christophe, Marin, Emilie, Safar, Violaine, Parcelier, Anne, Maisonneuve, Hervé, Bachy, Emmanuel, Cartron, Guillaume, Jaccard, Arnaud, Tournilhac, Olivier, Rossi, Cédric, Schirmer, Luciane, Martignoles, Jean-Alain, Gaulard, Philippe, Tilly, Hervé, Damaj, Gandhi
Publicado no Oncotarget (2016)